TY - JOUR
T1 - Early-Onset Colorectal Cancer
T2 - A Call for Greater Rigor in Epidemiologic Studies
AU - Molmenti, Christine Louise S.
AU - Jacobs, Elizabeth T.
AU - Gupta, Samir
AU - Thomson, Cynthia A.
N1 - Publisher Copyright:
© 2022 The Authors.
PY - 2022/3
Y1 - 2022/3
N2 - The rates of early-onset colorectal cancer (EO-CRC) have been rising by 0.5% to 2.4% annually for three decades, accounting for an estimated 12% of all colorectal cancer diagnosed in the United States in 2020. Enhancing the rigor and comprehensiveness of the epidemiology in terms of the exposures and prognostic biomarkers is essential if we are to modify risk factors and underlying mechanisms, ultimately arresting this unduly trend. This commentary serves to describe the disease trend, postulate underlying risk factors and mechanisms driving disease incidence, and proposes a call to action for cancer epidemiologists to promote increased and timely opportunities to intervene on this trend.
AB - The rates of early-onset colorectal cancer (EO-CRC) have been rising by 0.5% to 2.4% annually for three decades, accounting for an estimated 12% of all colorectal cancer diagnosed in the United States in 2020. Enhancing the rigor and comprehensiveness of the epidemiology in terms of the exposures and prognostic biomarkers is essential if we are to modify risk factors and underlying mechanisms, ultimately arresting this unduly trend. This commentary serves to describe the disease trend, postulate underlying risk factors and mechanisms driving disease incidence, and proposes a call to action for cancer epidemiologists to promote increased and timely opportunities to intervene on this trend.
UR - http://www.scopus.com/inward/record.url?scp=85125838358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125838358&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-21-0857
DO - 10.1158/1055-9965.EPI-21-0857
M3 - Article
C2 - 35253042
AN - SCOPUS:85125838358
SN - 1055-9965
VL - 31
SP - 507
EP - 511
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 3
ER -